Illumina, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Illumina, Inc.

Patent Number:
Title:
Massive Parallel Method For Decoding Dna And Rna
Opposition Date:
Oct 29, 2019

Latest patents of Illumina, Inc. opposed by its competitors

Patent:
Grant Date:
Oct 11, 2023
Title:
Dna Sequencing Using Hydrogel Beads
Oppositions:
1
Patent:
Grant Date:
Aug 30, 2023
Title:
Error Suppression In Sequenced Dna Fragments Using Redundant Reads With Unique Molecular Indices (Umis)
Oppositions:
1
Patent:
Grant Date:
Jun 28, 2023
Title:
Spatially Distinguished, Multiplex Nucleic Acid Analysis Of Biological Specimens
Oppositions:
1
Patent:
Grant Date:
Jun 28, 2023
Title:
Spatially Distinguished, Multiplex Nucleic Acid Analysis Of Biological Specimens
Oppositions:
2
Patent:
Grant Date:
Jan 4, 2023
Title:
Polynucleotide Enrichment Using Crispr-Cas Systems
Oppositions:
1
Patent:
Grant Date:
Nov 23, 2022
Title:
Spatially Distinguished, Multiplex Nucleic Acid Analysis Of Biological Specimens
Oppositions:
1
Patent:
Grant Date:
Mar 3, 2021
Title:
Modified Polymerases For Improved Incorporation Of Nucleotide Analogues
Oppositions:
1
Patent:
Grant Date:
Jul 22, 2020
Title:
Methods And Compositions For Nucleic Acid Sequencing
Oppositions:
1
Patent:
Grant Date:
Oct 24, 2018
Title:
Gene Expression Analysis In Single Cells
Oppositions:
3
Patent:
Grant Date:
Oct 17, 2018
Title:
Methods And Systems For Aligning Repetitive Dna Elements
Oppositions:
1

Want to track Illumina, Inc.?

Feel free to send us a message here and we will get back to you